The FDA wants to pull its approval of a drug. It’s not so easy.
Photo: Ars TechnicaThe regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?
Originally published by Ars Technica. Summary and curation by DutyStation News.
